Eschenbach Plans Broad Changes to Implement 'Aggressive' FDA Agenda

Drug Industry Daily
KEYWORDS FDA
A A

Acting FDA Commissioner Andrew von Eschenbach is proposing a multi-pronged strategy to enhance the agency's response to public health threats, including cancer and pandemic flu.

To View This Article:

Login

Subscribe To Drug Industry Daily